SCHEMBL4780425

SCHEMBL4780425

O=C(Nc1cccc2cnccc12)NC1C2CN(C(=O)c3ccccc3Br)CC21

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 18/20 0.49
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
CDK5 Q00535 1/20 0.43
CYP3A4 P08684 1/20 0.43
CHEK1 O14757 1/20 0.42
PIM1 P11309 1/20 0.42
CDK8 P49336 1/20 0.42
GSK3B P49841 1/20 0.42
CDK7 P50613 1/20 0.42
CDK9 P50750 1/20 0.42
LIMK1 P53667 1/20 0.42
ROCK1 Q13464 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4780244 0.89 TRPV1 (0.50) TRPV1CCNE1CDK2CDK5
SCHEMBL4778989 0.89 KDM4E (0.49) TRPV1CCNE1CDK2CDK5CYP3A4
SCHEMBL4778224 0.85 TRPV1 (0.53) TRPV1CCNE1CDK2CDK5CYP3A4
SCHEMBL4778931 0.82 TRPV1 (0.55) TRPV1CCNE1CDK2CDK5ROCK1
SCHEMBL4774396 0.82 TRPV1 (0.49) TRPV1CCNE1CDK2CDK5CYP3A4
SCHEMBL4778207 0.82 TRPV1 (0.49) TRPV1CCNE1CDK2CDK5CYP3A4
SCHEMBL4778063 0.81 CHRM1 (0.48) TRPV1
SCHEMBL4778071 0.81 CCNE1 (0.46) TRPV1CCNE1CDK2CDK5CYP3A4
SCHEMBL4777147 0.80 TRPV1 (0.52) TRPV1
SCHEMBL4779260 0.80 TRPV1 (0.52) TRPV1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008010061-A2 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2008-01-24 WO claimed
WO-2008010061-A2 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2008-01-24 WO disclosed